---
title: 'CSF and plasma biomarkers in cerebral amyloid angiopathy: A single-center
  study and a systematic review/meta-analysis'
date: '2024-06-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38869035/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240613182215&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: CAA is characterized by a distinct CSF biomarker pattern
  compared to HC and AD. CSF Aβ40 levels are lower in CAA compared to HC and AD, while
  tau and p-tau levels are higher in CAA compared to HC, but lower in comparison to
  AD ...'
disable_comments: true
---
CONCLUSIONS: CAA is characterized by a distinct CSF biomarker pattern compared to HC and AD. CSF Aβ40 levels are lower in CAA compared to HC and AD, while tau and p-tau levels are higher in CAA compared to HC, but lower in comparison to AD ...